Gateway Investment Advisers LLC Decreases Position in Agilent Technologies, Inc. $A

Gateway Investment Advisers LLC cut its holdings in Agilent Technologies, Inc. (NYSE:AFree Report) by 82.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,355 shares of the medical research company’s stock after selling 60,057 shares during the period. Gateway Investment Advisers LLC’s holdings in Agilent Technologies were worth $1,641,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in A. State Street Corp increased its holdings in shares of Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after buying an additional 241,029 shares during the period. Geode Capital Management LLC boosted its holdings in Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after acquiring an additional 25,139 shares during the period. Morgan Stanley grew its position in Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after acquiring an additional 692,202 shares during the last quarter. Norges Bank bought a new position in Agilent Technologies during the 4th quarter worth approximately $549,158,000. Finally, Cantillon Capital Management LLC increased its stake in Agilent Technologies by 0.8% in the 4th quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock worth $423,945,000 after purchasing an additional 23,493 shares during the period.

Analysts Set New Price Targets

Several brokerages have weighed in on A. Piper Sandler began coverage on Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price objective for the company. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Wells Fargo & Company dropped their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Finally, Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $160.24.

Get Our Latest Research Report on Agilent Technologies

Agilent Technologies Trading Down 0.8%

A opened at $148.28 on Thursday. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The business has a 50 day simple moving average of $134.90 and a two-hundred day simple moving average of $125.30. The firm has a market capitalization of $41.88 billion, a price-to-earnings ratio of 29.78, a PEG ratio of 2.65 and a beta of 1.25.

Agilent Technologies (NYSE:AGet Free Report) last issued its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period last year, the company earned $1.31 EPS. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts predict that Agilent Technologies, Inc. will post 6.03 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were issued a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is 20.48%.

Agilent Technologies Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Further Reading

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.